Eris Lifesciences per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹51.46₹45.33₹25.85₹28.82₹28.10
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹51.39₹45.26₹25.81₹28.79₹28.07
₹281.78₹281.78₹209.57₹190.11₹161.48
₹240.41₹225.95₹212.46₹147.70₹123.92
—₹38.84₹78.19₹35.73₹21.45
₹17.41₹17.41₹66.81₹26.23−₹40.42
—₹0.00₹7.35₹0.00₹7.35
13.913.913.613.613.6
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ERIS₹1,163.60

Eris Lifesciences Ltd.

· Pharma & Health
₹ CrorePeersMANKINDAJANTPHARMTORNTPHARMEMCUREGRANULESCONCORDBIOINDGNCAPLIPOINTMcap ₹16,116 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS28.1028.8225.8545.3351.46
Diluted EPS28.0728.7925.8145.2651.39
Book Value per Share161.48190.11209.57281.78281.78
Revenue per Share123.92147.70212.46225.95240.41
Cash Flow per Share21.4535.7378.1938.84—
Free Cash Flow per Share-40.4226.2366.8117.4117.41
Dividends per Share7.350.007.350.00—
Shares Outstanding (cr)13.613.613.613.913.9
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.